Marta Di Martile
Rome, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
Challenges and advances in drug resistance and tolerance in cancer.
Journal: Journal of experimental & clinical cancer research : CR
Published: January 21, 2026
PROTAC-based protein degradation: a window of opportunity for melanoma therapy.
Journal: Journal of biomedical science
Published: September 18, 2025
PROTAC-mediated degradation of Bcl-xL potentiates target therapy in preclinical melanoma models.
Journal: Journal of experimental & clinical cancer research : CR
Published: August 25, 2025
Semaphorin 5A modulates focal adhesion pathway and lamellipodia formation in melanoma.
Journal: Cell communication and signaling : CCS
Published: July 29, 2025
Androgen receptor inhibition sensitizes glioblastoma stem cells to temozolomide by the miR-1/miR-26a-1/miR-487b signature mediated WT1 and FOXA1 silencing.
Journal: Cell death discovery
Published: March 18, 2025
Induction of cell death by the CXCR2 antagonist SB225002 in colorectal cancer and stromal cells.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: February 14, 2025
LVI and DI-SPME Combined with GC/MS and GC/MS for Volatile Chemical Profile Investigation and Cytotoxic Power Evaluation of Essential Oil and Hydrolate from Cannabis sativa L. cv. Carmagnola.
Journal: Molecules (Basel, Switzerland)
Published: June 02, 2024
Bcl-2 dependent modulation of Hippo pathway in cancer cells.
Journal: Cell communication and signaling : CCS
Published: January 23, 2024
Upregulated expression of miR-4443 and miR-4488 in drug resistant melanomas promotes migratory and invasive phenotypes through downregulation of intermediate filament nestin.
Journal: Journal of experimental & clinical cancer research : CR
Published: August 21, 2023
Exploring association of melanoma-specific Bcl-xL with tumor immune microenvironment.
Journal: Journal of experimental & clinical cancer research : CR
Published: February 23, 2023
Bcl-2 family inhibitors sensitize human cancer models to therapy.
Journal: Cell death & disease
Published: January 18, 2023
Phytochemicals as Immunomodulatory Agents in Melanoma.
Journal: International journal of molecular sciences
Published: December 29, 2022
Last Updated: 09/26/2026